[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lori S. Friedman<\/i><\/u><\/presenter>. ORIC Pharmaceuticals, South San Francisco, CA","CSlideId":"","ControlKey":"5f153446-4b04-4012-956b-aae7a1a7902c","ControlNumber":"11204","DisclosureBlock":"","End":"4\/7\/2024 3:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"9828","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lori Friedman, PhD","PresenterKey":"be1429df-78dc-49c6-af11-d646a16b9064","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Cochairperson","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cochairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Hong Shen<\/i><\/u><\/presenter>. Roche R&D Center (China) Ltd., Shanghai, China","CSlideId":"","ControlKey":"4ea3dc7b-d214-4e69-aceb-7cc97080ee92","ControlNumber":"11205","DisclosureBlock":"","End":"4\/7\/2024 3:01:00 PM","HasWebcast":null,"Highlights":[],"Id":"9829","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Hong Shen, PhD","PresenterKey":"52424625-deb9-4c97-a28f-8694e75201e7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Cochairperson","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Cochairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Hong Shen<\/i><\/u><\/presenter>. Roche R&D Center (China) Ltd., Shanghai, China","CSlideId":"","ControlKey":"1184cd01-7cdc-4f2f-8bf1-9ee07b399a58","ControlNumber":"11343","DisclosureBlock":"","End":"4\/7\/2024 3:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"9984","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Hong Shen, PhD","PresenterKey":"52424625-deb9-4c97-a28f-8694e75201e7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Introduction","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Introduction","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++CH01-09 Targeted protein degradation,,"},{"Key":"Keywords","Value":"Proteasome-mediated degradation,Non-Hodgkin's lymphoma,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Dan Sherman<\/i><\/u><\/presenter>. Arvinas, Inc., New Haven, CT","CSlideId":"","ControlKey":"7b7eec49-a644-4c1a-9fe1-2a692b57f561","ControlNumber":"11206","DisclosureBlock":"","End":"4\/7\/2024 3:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"9830","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND05","PresenterBiography":null,"PresenterDisplayName":"Dan Sherman, BA","PresenterKey":"dc835644-13d5-43ec-ba7a-7a7bde9e8fb4","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND05. The discovery of ARV-393, a potent, orally bioavailable BCL6 targeting PROTAC&#174; for the treatment of Non-Hodgkin&#8217;s Lymphoma","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"The discovery of ARV-393, a potent, orally bioavailable BCL6 targeting PROTAC&#174; for the treatment of Non-Hodgkin&#8217;s Lymphoma","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"a4e75fbc-1a81-46c9-9798-6f5b26da74f5","ControlNumber":"11232","DisclosureBlock":"","End":"4\/7\/2024 3:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"9856","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++CH01-04 Drug design,,"},{"Key":"Keywords","Value":"CDK2,CDK4\/6 inhibitors,Breast cancer,ovarian cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christopher R. Denz<\/i><\/u><\/presenter>, <presenter><i>Michael Grondine<\/i><\/presenter>, <presenter><i>Jun Fan<\/i><\/presenter>, <presenter><i>Jessie Hao-Ru Hsu<\/i><\/presenter>, <presenter><i>Anne Jackson<\/i><\/presenter>, <presenter><i>James Robinson<\/i><\/presenter>, <presenter><i>Grace Guo<\/i><\/presenter>, <presenter><i>Wen Li<\/i><\/presenter>, <presenter><i>Yanjun Wang<\/i><\/presenter>, <presenter><i>Maryann San Martin<\/i><\/presenter>, <presenter><i>Laura Prickett<\/i><\/presenter>, <presenter><i>Jeffrey Johannes<\/i><\/presenter>, <presenter><i>Avipsa Ghosh<\/i><\/presenter>, <presenter><i>Kun Song<\/i><\/presenter>, <presenter><i>Dhivya Sudhan<\/i><\/presenter>, <presenter><i>Christina Vasalou<\/i><\/presenter>, <presenter><i>Ryan Richards<\/i><\/presenter>, <presenter><i>Kevin Beaumont<\/i><\/presenter>, <presenter><i>Matthew Peters<\/i><\/presenter>, <presenter><i>Lisa Drew<\/i><\/presenter>, <presenter><i>Stephen Fawell<\/i><\/presenter>, <presenter><i>Frederick W. Goldberg<\/i><\/presenter>. AstraZeneca Pharmaceuticals LP, Waltham, MA","CSlideId":"","ControlKey":"ed4c6876-3d16-4f8a-9285-79ea4c9914df","ControlNumber":"11207","DisclosureBlock":"","End":"4\/7\/2024 3:40:00 PM","HasWebcast":null,"Highlights":[],"Id":"9831","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND06","PresenterBiography":null,"PresenterDisplayName":"Christopher Denz, MS","PresenterKey":"87563adf-2c83-4269-befb-df2d152f177e","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND06. First disclosure of AZD8421, a highly selective CDK2 inhibitor to address resistance to CDK4\/6 inhibitors in breast and CCNE1-high cancers","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"First disclosure of AZD8421, a highly selective CDK2 inhibitor to address resistance to CDK4\/6 inhibitors in breast and CCNE1-high cancers","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"22b12221-a1cd-4946-9736-fbf7fca28bae","ControlNumber":"11233","DisclosureBlock":"","End":"4\/7\/2024 3:45:00 PM","HasWebcast":null,"Highlights":[],"Id":"9857","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:40:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++ET09-05 Novel antitumor agents,,"},{"Key":"Keywords","Value":"KRAS,NSCLC,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><i>Anna E. Maciag<\/i><\/presenter>, <presenter><i>James Stice<\/i><\/presenter>, <presenter><i>Bin Wang<\/i><\/presenter>, <presenter><i>Alok Sharma<\/i><\/presenter>, <presenter><i>Albert Chan<\/i><\/presenter>, <presenter><i>Ken Lin<\/i><\/presenter>, <presenter><i>Devansh Singh<\/i><\/presenter>, <presenter><i>Marcin Dyba<\/i><\/presenter>, <presenter><i>Yue Yang<\/i><\/presenter>, <presenter><i>Saman Setoodeh<\/i><\/presenter>, <presenter><i>Brian P. Smith<\/i><\/presenter>, <presenter><i>Dana Rabara<\/i><\/presenter>, <presenter><i>Zuhui Zhang<\/i><\/presenter>, <presenter><i>Erik K. Larsen<\/i><\/presenter>, <presenter><i>Dom Esposito<\/i><\/presenter>, <presenter><i>John Paul Denson<\/i><\/presenter>, <presenter><i>Michela Ranieri<\/i><\/presenter>, <presenter><i>Mary Meynardie<\/i><\/presenter>, <presenter><i>Sadaf Mehdizadeh<\/i><\/presenter>, <presenter><i>Patrick Alexander<\/i><\/presenter>, <presenter><i>Maria Abreu Blanco<\/i><\/presenter>, <presenter><i>David Turner<\/i><\/presenter>, <presenter><i>Rui Xu<\/i><\/presenter>, <presenter><i>Felice C. Lightstone<\/i><\/presenter>, <presenter><i>Kwok Kin Wong<\/i><\/presenter>, <presenter><i>Dhirendra Simanshu<\/i><\/presenter>, <presenter><i>Keshi Wang<\/i><\/presenter>, <presenter><i>Andrew G. Stephen<\/i><\/presenter>, <presenter><i>Kerstin Sinkevicius<\/i><\/presenter>, <presenter><i>Dwight V. Nissley<\/i><\/presenter>, <presenter><i>Eli Wallace<\/i><\/presenter>, <presenter><i>Frank McCormick<\/i><\/presenter>, <presenter><u><i>Pedro J. Beltran<\/i><\/u><\/presenter>. NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, BridgeBio Pharma, Inc., San Francisco, CA, Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, CA, Perlmutter Cancer Center, New York University, New York, NY, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA","CSlideId":"","ControlKey":"5f2b7d8a-7e4b-4481-bc37-76d902408baf","ControlNumber":"11208","DisclosureBlock":"","End":"4\/7\/2024 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"9832","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND07","PresenterBiography":null,"PresenterDisplayName":"Pedro Beltran, PhD","PresenterKey":"cd7f5082-37c5-44b7-98d1-b29e1e9a1f08","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND07. BBO-8520, a first-in-class, direct inhibitor of KRAS<sup>G12C<\/sup> (ON), locks GTP-bound KRAS<sup>G12C<\/sup> in the state 1 conformation resulting in rapid and complete blockade of effector binding","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 3:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"BBO-8520, a first-in-class, direct inhibitor of KRAS<sup>G12C<\/sup> (ON), locks GTP-bound KRAS<sup>G12C<\/sup> in the state 1 conformation resulting in rapid and complete blockade of effector binding","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"b0d609db-992b-4d24-9890-1dcafed24340","ControlNumber":"11234","DisclosureBlock":"","End":"4\/7\/2024 4:05:00 PM","HasWebcast":null,"Highlights":[],"Id":"9858","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 4:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":"++ET02-09 Other,,"},{"Key":"Keywords","Value":"Antibody-drug conjugate (ADC),Pediatric cancers,Sarcoma\/soft-tissue malignancies,GD2,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christiane Amendt<\/i><\/u><\/presenter>, <presenter><i>Christine Knuehl<\/i><\/presenter>, <presenter><i>Timothy Crandall<\/i><\/presenter>, <presenter><i>Willem Sloot<\/i><\/presenter>, <presenter><i>Mira Toister-Achituv<\/i><\/presenter>, <presenter><i>Stanley Sweeney-Lasch<\/i><\/presenter>, <presenter><i>Joao NS Pereira<\/i><\/presenter>, <presenter><i>Julia Dotterweich<\/i><\/presenter>, <presenter><i>Hans_Henning Boehm<\/i><\/presenter>, <presenter><i>Jianguo Ma<\/i><\/presenter>, <presenter><i>Jan Anderl<\/i><\/presenter>. The healthcare business of Merck KGaA, Darmstadt, Germany, EMD Serono, Billerica, MA, Inter-Lab Ltd., an affiliate of Merck KGaA, Darmstadt, Germany, Yavne, Israel","CSlideId":"","ControlKey":"c79eabfb-6c40-436c-b870-d5e6b50ffbcf","ControlNumber":"11209","DisclosureBlock":"","End":"4\/7\/2024 4:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"9833","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"ND08","PresenterBiography":null,"PresenterDisplayName":"Christiane Amendt, PhD","PresenterKey":"e12c5b15-8262-48af-af77-a4431f86e10e","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"ND08. <b>M3554, a novel anti-GD2 antibody drug conjugate<\/b>","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 4:05:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"<b>M3554, a novel anti-GD2 antibody drug conjugate<\/b>","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"e752dd16-68eb-4d93-bc6a-00f6e7a95601","ControlNumber":"11235","DisclosureBlock":"","End":"4\/7\/2024 4:25:00 PM","HasWebcast":null,"Highlights":[],"Id":"9859","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"11","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 4:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lori S. Friedman<\/i><\/u><\/presenter>. ORIC Pharmaceuticals, South San Francisco, CA","CSlideId":"","ControlKey":"955c9595-a41a-4b85-bc07-12bff6a38a33","ControlNumber":"11335","DisclosureBlock":"","End":"4\/7\/2024 4:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"9976","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"12","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lori Friedman, PhD","PresenterKey":"be1429df-78dc-49c6-af11-d646a16b9064","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Closing remarks","SearchResultFooter":"","SearchResultHeader":"Apr  7 2024  3:00PM","SessionId":"553","SessionOnDemand":"False","SessionTitle":"New Drugs on the Horizon: Part 2","ShowChatLink":"false","Start":"4\/7\/2024 4:25:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Closing remarks","Topics":null,"cSlideId":""}]